Zimmer Biomet Holdings (ZBH) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -18.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.61% |
| Dec 31, 2025 | 45.24% |
| Sep 30, 2025 | 23.60% |
| Jun 30, 2025 | -4.93% |
| Mar 31, 2025 | -19.06% |
| Dec 31, 2024 | -17.99% |
| Sep 30, 2024 | -47.21% |
| Jun 30, 2024 | -45.84% |
| Mar 31, 2024 | 17.99% |
| Dec 31, 2023 | -0.95% |
| Sep 30, 2023 | 78.60% |
| Jun 30, 2023 | 137.90% |
| Mar 31, 2023 | 28.30% |
| Dec 31, 2022 | 28.86% |
| Sep 30, 2022 | 7.27% |
| Jun 30, 2022 | 66.26% |
| Mar 31, 2022 | 41.09% |
| Dec 31, 2021 | 122.62% |
| Sep 30, 2021 | 43.79% |
| Jun 30, 2021 | 29.47% |
| Mar 31, 2021 | -35.82% |
| Dec 31, 2020 | -57.34% |
| Sep 30, 2020 | -47.78% |
| Jun 30, 2020 | -67.74% |
| Mar 31, 2020 | 6.35% |
| Dec 31, 2019 | 9.05% |
| Sep 30, 2019 | -4.72% |
| Jun 30, 2019 | 118.15% |
| Mar 31, 2019 | 41.57% |
| Dec 31, 2018 | 2.81% |
| Sep 30, 2018 | 70.83% |
| Jun 30, 2018 | -12.05% |
| Mar 31, 2018 | -38.05% |
| Dec 31, 2017 | -15.38% |
| Sep 30, 2017 | -36.17% |
| Jun 30, 2017 | -33.41% |
| Mar 31, 2017 | 56.16% |
| Dec 31, 2016 | 11.20% |
| Sep 30, 2016 | 4.83% |
| Jun 30, 2016 | 51.64% |
| Mar 31, 2016 | -19.77% |
| Dec 31, 2015 | -0.20% |
| Sep 30, 2015 | 66.56% |
| Jun 30, 2015 | -5.00% |
| Mar 31, 2015 | 9.55% |
| Dec 31, 2014 | 115.79% |
| Sep 30, 2014 | -12.47% |
| Jun 30, 2014 | 42.86% |
| Mar 31, 2014 | 75.42% |
| Dec 31, 2013 | -47.34% |
| Sep 30, 2013 | 36.16% |
| Jun 30, 2013 | -9.68% |
| Mar 31, 2013 | -8.21% |
| Dec 31, 2012 | -5.87% |
| Sep 30, 2012 | -19.82% |
| Jun 30, 2012 | 46.75% |
| Mar 31, 2012 | 14.04% |
| Dec 31, 2011 | 19.17% |
| Sep 30, 2011 | 143.17% |
| Jun 30, 2011 | 11.92% |
| Mar 31, 2011 | 47.41% |
| Dec 31, 2010 | 36.40% |
| Sep 30, 2010 | -37.10% |
| Jun 30, 2010 | -36.55% |
| Mar 31, 2010 | -62.46% |